Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01607905
Title Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced or Metastatic Solid Tumor Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Indications

colorectal cancer

lung non-small cell carcinoma

peritoneal carcinoma

ovarian carcinoma

head and neck squamous cell carcinoma

fallopian tube carcinoma

prostate cancer

Advanced Solid Tumor

cervix carcinoma

malignant astrocytoma

glioblastoma

Therapies

Selinexor

Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Princess Margaret Hospital Toronto Ontario M5T 2M9 Canada Details
Rigshospitalet Copenhagen 2100 Denmark Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field